Adam W. Grasso
About
In The Last Decade
Adam W. Grasso
6 papers receiving 842 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Surgery 411
- Molecular Biology 261
- Endocrinology, Diabetes and Metabolism 249
- Pulmonary and Respiratory Medicine 190
- Cardiology and Cardiovascular Medicine 148
Countries citing papers authored by Adam W. Grasso
This map shows the geographic impact of Adam W. Grasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam W. Grasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam W. Grasso more than expected).
Fields of papers citing papers by Adam W. Grasso
This network shows the impact of papers produced by Adam W. Grasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam W. Grasso. The network helps show where Adam W. Grasso may publish in the future.
Co-authorship network of co-authors of Adam W. Grasso
This figure shows the co-authorship network connecting the top 25 collaborators of Adam W. Grasso. A scholar is included among the top collaborators of Adam W. Grasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam W. Grasso. Adam W. Grasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis breakdown → | 543 |
| 2 | 15 | |
| 3 | 52 | |
| 4 | A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. | 145 |
| 5 | 126 | |
| 6 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.